Skip to content
2000
Volume 21, Issue 5
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Docosahexaenoic Acid (DHA) supplementation is regarded as safe and beneficial to maternal health before, during, and after pregnancy. DHA is indeed an important fatty acid, and its requirement is elevated during pregnancy due to fetal brain and eye development requirements. Despite its established importance, there is no established Recommended Dietary Allowance (RDA) for DHA, unlike other essential nutrients. The other gap in the estimated average minimum required intake is due to individual differences in the needs of DHA among individuals. This depends on an individual’s diet, metabolism, and genetic effects. Although there are guides on the minimum daily intake, measurement using blood tests still remains the best way to determine an individual's needs. Therefore, patients should first consider monitoring their DHA concentration and then adjust supplementation according to personal requirements. Among the existing choices of DHA supplementations, traditional soft-gel capsules present some drawbacks lower stability, lower bioavailability, and organoleptic problems such as a fishy aftertaste. The emulsion-based DHA formulations, on the other hand, offer a better alternative with higher stability, better bioavailability, and a favorable taste profile. Therefore, the editorial highlights the need for tailored approaches such as estimating the baseline reference range in individuals’ blood and then supplementing the individual with DHA using novel delivery systems, such as emulsions. These tailored approaches will further enhance maternal and fetal health.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnf/10.2174/0115734013338932241204040840
2025-01-22
2025-10-21

  • From This Site

    /content/journals/cnf/10.2174/0115734013338932241204040840
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MuccioliM. Optimizing nutrition during pregnancy with diabetes.Available from: https://www.diabetesdaily.com/learn-about-diabetes/living-with-diabetes/pregnancy-and-diabetes-what-you-need-to-know-2/optimizing-nutrition-during-pregnancy-with-diabetes/ [cited: 2021 Sep 6].2018
  2. GautamC.P. RaniA. FreemanD.J. Distribution of fatty acids and lipids during pregnancy.Adv Clin Chem201884209239
     [Google Scholar]
  3. ThakurS SharmaR JainSK Prenatal supplementation of docosahexaenoic acid for the management of preterm births: Clinical information for practice.Curr Pediatr Rev2024204489499
     [Google Scholar]
  4. SinghH. ThakurS. SahajpalN.S. SinghH. SinghA. SohalH.S. JainS.K. Recent advances in the novel formulation of docosahexaenoic acid for effective delivery, associated challenges and its clinical importance.Curr Drug Deliv202017648350432394831
     [Google Scholar]
  5. ThakurS JainSK Proteins in complement, immune, and clotting cascades and their role in preterm births.Curr Protein Pept Sci20232442335
     [Google Scholar]
  6. UrquizaD.AM LiuS SjobergM Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain.Science200029054992140410.1126/science.290.5499.2140
     [Google Scholar]
  7. WatanabeY TatsunoI. Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: A review of the state-of-the-art.Expert Rev Clin Pharmacol2021147993
     [Google Scholar]
  8. BasakS MallickR DuttaroyAK Maternal docosahexaenoic acid status during pregnancy and its impact on infant neurodevelopment.Nutrients20201212361510.3390/nu12123615
     [Google Scholar]
  9. LauritzenL BrambillaP MazzocchiA HarsløfLBS CiappolinoV AgostoniC DHA effects in brain development and function.Nutrients201681610.3390/nu8010006
     [Google Scholar]
  10. InnisSM Fatty acids and early human development.Early Hum Dev20078312761610.1016/j.earlhumdev.2007.09.004
     [Google Scholar]
  11. CarlsonSE GajewskiBJ ValentineCJ Assessment of DHA on reducing early preterm birth: The ADORE randomized controlled trial protocol.BMC Pregnancy Childbirth201717162
     [Google Scholar]
  12. CarlsonSE ColomboJ GajewskiBJ DHA supplementation and pregnancy outcomes.Am J Clin Nutr20139748081510.3945/ajcn.112.050021
     [Google Scholar]
  13. ThakurS KaurAP SinghK Reference range of plasma fatty acids in north indian pregnant population.Indian J Clin Biochem2022384519527
     [Google Scholar]
  14. ThakurS SinghA KaurM Vitamins and minerals fortified emulsion of omega-3 fatty acids for the management of preterm birth: In-vitro, in-silico, and in-vivo studies.J. Drug Deliv. Sci. Technol.202383104409
     [Google Scholar]
  15. SinghH SinghJ SinghSK Vitamin E TPGS based palatable, oxidatively and physically stable emulsion of microalgae DHA oil for infants, children and food fortification.J. Disp. Sci. Techn.202041111674168910.1080/01932691.2019.1634587
     [Google Scholar]
/content/journals/cnf/10.2174/0115734013338932241204040840
Loading
DHA Supplement in Pregnant Women Life's Flow: Measure Before You Bestow
Curr. Nutr. Food Sci. 21, 575 (2025); https://doi.org/10.2174/0115734013338932241204040840
/content/journals/cnf/10.2174/0115734013338932241204040840
/content/journals/cnf/10.2174/0115734013338932241204040840
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): baseline reference range; Docosahexaenoic acid; fatty acids; plasma concentrations; pregnant women; preterm birth

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test